DekaBank Deutsche Girozentrale
ONCE

DekaBank Deutsche Girozentrale’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,164
Closed -$1.04M – 1175
2019
Q2 		$1.04M Sell
10,164
-11,286
-53% -$1.22M 0.01% 776
2019
Q1 		$1.34M Sell
21,450
-61,400
-74% -$4.51M 0.01% 702
2018
Q4 		$3.07M Buy
82,850
+61,400
+286% +$2.66M 0.02% 457
2018
Q3 		$1.34M Sell
21,450
-550
-3% -$37.6K 0.01% 713
2018
Q2 		$1.82M Buy
22,000
+6,000
+38% +$463K 0.01% 607
2018
Q1 		$1.05M Buy
16,000
+2,200
+16% +$127K 0.01% 707
2017
Q4 		$1.09M Hold
13,800
– – 0.01% 669
2017
Q3 		$1.09M Hold
13,800
– – 0.01% 677
2017
Q2 		$829K Buy
+13,800
New +$771K 0.01% 736
2016
Q3 		– Sell
-13,800
Closed -$679K – 1051
2016
Q2 		$679K Buy
13,800
+3,100
+29% +$132K 0.01% 619
2016
Q1 		$338K Buy
+10,700
New +$337K ﹤0.01% 731

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ONCE Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 10,164 shares — an estimated $1.04M sold.

DekaBank Deutsche Girozentrale first reported a position in ONCE in Q1 2016 and held it in 11 quarters. The position peaked at $3.07M in Q4 2018. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 10,164 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.04M.
  • DekaBank Deutsche Girozentrale first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 11 quarters.
  • DekaBank Deutsche Girozentrale's Spark Therapeutics, Inc. Common Stock position peaked at $3.07M in Q4 2018.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.